Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia

BACKGROUND: Acute myeloid leukemia (AML) is curable in a subset of cases. The DNA methylation regulator TET2 is frequently mutated in AML, and we hypothesized that studying TET2-specific differentially methylated CpGs (tet2-DMCs) improves AML classification. METHODS: We used bisulfite pyrosequencing...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Natl Cancer Inst
Hlavní autoři: Yamazaki, Jumpei, Taby, Rodolphe, Jelinek, Jaroslav, Raynal, Noel J. M., Cesaroni, Matteo, Pierce, Sherry A., Kornblau, Steven M., Bueso-Ramos, Carlos E., Ravandi, Farhad, Kantarjian, Hagop M., Issa, Jean-Pierre J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862435/
https://ncbi.nlm.nih.gov/pubmed/26568194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv323
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky